132 related articles for article (PubMed ID: 19917182)
1. Development of alopecia areata after biological therapy with TNF-alpha Blockers: description of a case and review of the literature.
Hernández MV; Nogués S; Ruiz-Esquide V; Alsina M; Cañete JD; Sanmartí R
Clin Exp Rheumatol; 2009; 27(5):892-3. PubMed ID: 19917182
[No Abstract] [Full Text] [Related]
2. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
Fabre C; Dereure O
Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
[No Abstract] [Full Text] [Related]
3. Alopecia areata during etanercept therapy.
Pan Y; Rao NA
Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
[TBL] [Abstract][Full Text] [Related]
4. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
[TBL] [Abstract][Full Text] [Related]
5. Alopecia areata in a patient receiving infliximab.
Ormaechea-Pérez N; López-Pestaña A; Muñagorri-Santos AI; Moreno AJ; Tuneu-Valls A
Indian J Dermatol Venereol Leprol; 2013; 79(4):529-31. PubMed ID: 23760327
[No Abstract] [Full Text] [Related]
6. Alopecia areata following adalimumab.
Kirshen C; Kanigsberg N
J Cutan Med Surg; 2009; 13(1):48-50. PubMed ID: 19298772
[TBL] [Abstract][Full Text] [Related]
7. [Alopecia areata during anti-TNF alpha therapy: Nine cases].
Le Bidre E; Chaby G; Martin L; Perrussel M; Sassolas B; Sigal ML; Kaassis C; Lespessailles E; Nseir A; Estève E
Ann Dermatol Venereol; 2011; 138(4):285-93. PubMed ID: 21497255
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata universalis elicited during treatment with adalimumab.
Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
Dermatology; 2008; 217(4):380. PubMed ID: 18849606
[No Abstract] [Full Text] [Related]
10. Concomitant alopecia areata and hypertrichosis after infliximab therapy: rara avis.
Akarsu S; Tok F; Tekin L
Acta Reumatol Port; 2013; 38(1):49-50. PubMed ID: 24131912
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata during treatment with biologic agents.
Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
[No Abstract] [Full Text] [Related]
12. Biologic agents and alopecia areata.
Katoulis AC; Alevizou A; Bozi E; Georgala S; Mistidou M; Kalogeromitros D; Stavrianeas NG
Dermatology; 2009; 218(2):184-5. PubMed ID: 19018127
[No Abstract] [Full Text] [Related]
13. Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
Marakli SS; Uzun S; Ozbek S; Tuncer I
Eur J Dermatol; 2008; 18(1):88-9. PubMed ID: 18086603
[No Abstract] [Full Text] [Related]
14. [Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab].
Gutierrez M; Becciolini A; Bertolazzi C; Di Geso L; Tardella M; Ariani A; Filippucci E; Grassi W
Reumatismo; 2010; 62(3):221-4. PubMed ID: 21052570
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
[TBL] [Abstract][Full Text] [Related]
16. Development of alopecia areata universalis in a patient receiving adalimumab.
Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
[No Abstract] [Full Text] [Related]
17. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab.
Cooper J; Flückiger B; Traichl B; Diener PA; Otto P; von Kempis J
J Clin Rheumatol; 2009 Aug; 15(5):244-6. PubMed ID: 19590442
[TBL] [Abstract][Full Text] [Related]
18. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
[TBL] [Abstract][Full Text] [Related]
19. Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers.
Lo Nigro A; Ramonda R; Alaibac M; Modesti V; Punzi L
Eur J Dermatol; 2011; 21(2):263-4. PubMed ID: 21411412
[No Abstract] [Full Text] [Related]
20. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles.
Ettefagh L; Nedorost S; Mirmirani P
Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
